ABSTRACT
Introduction
Intravenous patient-controlled analgesia (IV-PCA) with morphine is commonly used for postoperative pain control following major abdominal surgery. However, large amounts of morphine may lead to significant adverse events, such as respiratory depression, nausea, vomiting, or hypotension 1 .
Multimodal analgesia using a non-opioid analgesic, in addition to an opioid analgesic, has been suggested as a way to improve postoperative pain control and to reduce opioid use [2] [3] [4] [5] .
Since the mechanism of action differs from that of opioids, ketamine may be a useful adjunct to improve the management of perioperative pain. The potential benefit of adding ketamine to IV-PCA with morphine has been reported by a number of studies across several types of surgery [5] [6] [7] [8] [9] [10] [11] [12] .
Magnesium sulfate has also been previously investigated as a possible adjuvant for postoperative analgesia [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] . However; relatively few studies have been conducted on the effects of postoperative intravenous magnesium administration (as an infusion) over a 24-hour period 17, [21] [22] [23] .
The current prospective, randomized study aimed to compare the effects of magnesium sulfate and ketamine on postoperative pain and total morphine consumption in a placebocontrolled design. We also assessed the occurrence of adverse effects and the level of patient satisfaction.
Methods
The investigation was approved by the Ethics Committee under general anesthesia were enrolled in the study.
The exclusion criteria were patients with severe hepatic, renal, cardiovascular impairment, neurological or psychiatric disorders, with allergy to the study drugs, and with history of chronic pain, drug or alcohol abuse. Those with history of current regular use of analgesics, anticonvulsants, antidepressants, or opioids within the last month were excluded from the study.
Patients were randomly allocated into one of three equal groups (n = 40) with a computerized random number generator:
group K (ketamine bolus 0.2 mg/kg followed by infusion of 0.05 mg/kg/h, group M (magnesium bolus 50 mg/kg followed by 10 mg/kg/h infusion), and group C (normal saline). Study drugs were started in the postoperative period and continued for 48 h.
During the preoperative visit, the patients were informed about the purpose, and the use of the patient-controlled analgesia In the PACU, a physician, blinded to the groups, evaluated the severity of pain by using a Numeric Pain Rating Scale (NPRS, 0 = no pain, 10 = worst pain). When a NPRS score of 4 was reached, or the patient requested analgesic, a bolus dose of morphine 0.01 mg/kg was administered, and then the IV-PCA device containing
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A double-blind randomized controlled clinical study morphine 1 mg/mL was connected to the patients (bolus = 0.01 mg/kg, lock-out interval = 15 min, and continous background infusion = 0.03 mg/kg/h) 24 . It was continued throughout the 48 h study period.
Patients were randomly allocated into three equal groups (n = 40) with a computerized random number generator in a double-blinded manner: Total morphine consumption, the number of rescue analgesic given, and the level of the patient satisfaction were recorded at 48 h after surgery.
Demographic characteristics such as age, ASA, and duration of surgery were also recorded for all patients.
The physicians collecting the postoperative data, as well as the patients, were unaware of the infused solutions.
The primary endpoint was total morphine consumption 48 h after surgery. The secondary outcome measures were the pain scores, the presence of adverse effects, and the patient satisfaction levels.
Statistical analysis
The morphine consumption by PCA at the end of 48 hours was the primary outcome variable on which sample size estimation was based at the beginning of the study. A sample size of 25 per group was required to detect a difference in morphine consumption between treatments at a two-sided 5% significance level with a power of 90% 
Results
In the present study, a total of 120 patients met the inclusion criteria, and consented for the study. Patients were randomized to one of three groups (Figure 1 ). There were no dropouts or loss to follow-up. There were no significant differences among the three groups with respect to demographic data or the duration of the operation (Table 1) . Data are the mean ± SD. There were no significant differences among the groups.
The mean morphine consumption doses after 48 h was lowest in the ketamine group (p<0.05). There was no statistically significant difference between the control group and magnesium group (p>0.05). The NPRS at all time points were similar among the three groups (Table 2) . 
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Discussion
This study showed that the addition of ketamine to IV-PCA with morphine was associated with less morphine consumed, less number of patient needed rescue analgesic, and more patient satisfaction. The occurrence of pruritus and nausea were more frequent in morphine alone group. In our study, we observed that magnesium sulfate had no impact on morphine consumption. We did not find any differences among groups in terms of pain scores, and other side effects.
Intravenous patient-controlled analgesia (IV-PCA) with morphine is commonly used for postoperative pain control after major abdominal surgery. White et al. 26 concluded that the use of morphine infusion combined with PCA boluses may result in a better control of pain and lower morphine consumption. Therefore, in our study, we used this method. In addition, rescue analgesia with tenoxicam (20 mg, IV) was given Nesher et al. 11 reported that IV-PCA with a subanesthetic dose of ketamine and morphine following transthoracic lung and heart surgery resulted in lower pain scores, morphine consumption, and incidence of nausea-vomiting without increasing side effects.
Zakine et al. 12 compared ketamine infusion during the intraoperative period alone with that for the perioperative period Akhavanakbari et al. 28 showed that adding ketamine to morphine in IV-PCA reduced pain score and morphine consumption.
In this study, ketamine has been used only for the postoperative period without pre-or perioperative administration.
In line with the previous studies, we found that the morphine consumption was less in ketamine group, and the use of the low dose (0.05 mg/kg/h) of ketamine was not associated with any psychotic effects. These results were also confirmed in a previous study 3 .
Perioperative intravenous magnesium sulfate at very high doses has been reported to reduce postoperative morphine consumption but not postoperative pain scores 15 . Murphy et al. 29 found that the perioperative infusion of magnesium sulfate was associated with a decrease in postoperative opioid consumption; nevertheless, the decrease in opioid consumption was not associated with a decrease in opioid related side effects (eg, postoperative nausea and vomiting). In addition, they also found that perioperative magnesium sulfate infusion was associated with a decrease in visual analog scale pain scores up to 4-6 hours after surgery.
Ryu et al. 30 gave magnesium sulfate (50mg/kg bolus followed by 15mg/kg/h) or placebo intraoperatively to patients undergoing total abdominal hysterectomy under general anesthesia. They found that postoperative PCA morphine use and pain scores were lower in the magnesium group at 24 and 48 h, and PONV incidence was also lower than with placebo. Tramer et al. 15 reported that patients undergoing lower abdominal surgery with magnesium supplementation consumed 30% less morphine in the postoperative period compared with control patients. Ozcan et al. 21 found that postoperative use of magnesium sulfate reduced opioid consumption for pain after thoracotomy operations.
However; in our study, we did not find any positive effect of magnesium sulfate on morphine consumption. Lysakowski et al.
31
, in a systemic review of randomized trials, reached different conclusions as to whether magnesium sulfate is a useful adjuvant to postoperative analgesia. Their trials do not provide convincing evidence that perioperative magnesium sulfate has favorable effects on postoperative pain intensity and analgesic requirement.
Unlugenc et al. 23 compared the effects of magnesium sulfate with ketamine on postoperative analgesia and morphine consumption. They found that both drugs significantly reduced morphine consumption during the first 24 hours. In this study, the total morphine consumption was significantly lower in ketamine group, but we did not find any favorable effects of magnesium sulfate on morphine consumption. Postoperative pain scores were similar in all groups. The incidence of nausea and pruritus were more common in morphine alone group.
This study had some limitations. The present study was that pain scores were not recorded after the postoperative first 48
hours. Moreover, we evaluated the pain intensity only at rest. The analgesic effects of the study drugs on postoperative mobilization, and hospital discharge time were not evaluated. These effects should be addressed in future studies.
Conclusions
Patients in morphine alone group experienced more nausea and pruritus than in the other groups. The total consumption of morphine, and additional analgesic requirements were less, while the satisfaction level of patients were higher in the ketamine group. Ketamine is still one of the most advantageous adjuvant drugs for treating postoperative pain.
